Skip to main content
. 2005 Apr 1;115(5):1323–1332. doi: 10.1172/JCI23219

Figure 6.

Figure 6

Mean levels ± SD of HDL apoA-I (A), mean HDL apoA-I FSR (B), and mean HDL apoA-I PR (C) during placebo (black bars) and Pio (white bars) treatments. The results were derived from injection of D3-leucine as a precursor of apoA-I. There were no significant effects of Pio treatment on the levels or metabolism of HDL apoA-I.